| 1 |
Raha, A., Reddy, V, Houser, W.H., and Bresnick, E., Binding characteristics of 4S PAH-binding proteins and Ah receptor from rats and mice. J. Toxicol. Environ. Health 29, 339-355 (1990)
DOI
PUBMED
ScienceOn
|
| 2 |
Reyes, H., Reisz-Porszasz, S., and Hankinson, O., Identification of the Ah receptor nuclear translocator protein (Amt) as a component of the DNA binding form of the Ah receptor. Science 256(5060), 1193-1195 (1992)
DOI
PUBMED
ScienceOn
|
| 3 |
Siegfried, Z., and Cedar, H., DNA methylation: a molecular lock. Curr. Biol. 7(5), R305-307 (1997)
DOI
ScienceOn
|
| 4 |
Silver, G, and Krauter, K.S., Aryl hydrocarbon induction of ratcytochrome P-450d results from increased precursor RNAprocessing. Mol Cell. Biol. 10(12), 6765-8 (1990)
DOI
|
| 5 |
Sinclair, P.R., Bement, W.J., Lambrecht, R.W., Gorman, N., and Sinclair, J.R, Chlorinated biphenyls induce cytochrome P450IA2 and uroporphyrin accumulation in cultures of mouse hepatocytes. Arch. Biochem. Biophys. 281(2), 225-232 (1990)
DOI
ScienceOn
|
| 6 |
Tuteja, N., Gonzalez, F.J., and Nebert, D.W., Developmental and tissue-speciSc differential regulation of the mouse dioxin-in ducible P1-450 and P3-450 genes. Dev. Biol. 112(1), 177-184 (1985)
DOI
ScienceOn
|
| 7 |
Vistisen, K., Poulsen, H.E., and Loft, S., Foreign compound metabolism capacity in man measured from metabolites of dietary caffeine. Carcinogenesis 13(9), 1561-1568 (1992)
DOI
ScienceOn
|
| 8 |
Whitlock, J.P. Jr., Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Annu. Rev. Pharmacol. Toxicol. 30, 251-277 (1990)
DOI
PUBMED
ScienceOn
|
| 9 |
Wu, C., Chromatin remodeling and the control of gene expression. J. Biol. Chem. 272(45), 28171-28174 (1997)
DOI
ScienceOn
|
| 10 |
Aitchison, K.J., Gonzalez, F.J., Quattrochi, L.C., Sapone, A., Zhao, J.H., Zaher, H., Elizondo, G., Bryant, C., Munro, J., Collier, D.A., Makoffa, A.I., and Kerwin, R.W., Identification of novel polymorphisms in the 5' flanking region of CYP1A2, characterization of interethnic variability, and investigation of their functional significance. Phannacogenetics 10(8), 695-704 (2000)
DOI
ScienceOn
|
| 11 |
Angel, P. and K-arin, M., The role of Jun, Fos and the AP-l complex in cell-proliferation and transformation. Biochim. Biophys. Acta. 1072(2-3), 129-157 (1991)
|
| 12 |
Barnett, C.R., Wilson, J., Wolf, C.R., Ratt, P.R., and loannides, C., Hyperinsulinaemia causes a preferential increase in hepatic P4501A2 activity. Biochem. Phai-macol. 43(6), 1255-1261 (1992)
DOI
ScienceOn
|
| 13 |
Chung, I. and Jung, K., No role of Protected Region B of Human Cytochrome P4501A2 Gene (CYP1A2) As an AP-l Response Element. Arch. Pharm. Res. 25(3), 375-380 (2002)
DOI
ScienceOn
|
| 14 |
Corchero, J., Pimprale, S., Kimura, S., and Gonzalez, F.J., Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation. Pharmacogenetics 11(1), 1-6 (2001)
DOI
ScienceOn
|
| 15 |
Gonzalez, F.J. and Gelboin, H.V, Role of human cytochrome P-450s in risk assessment and susceptibility to environmentally based disease. J. Toxicol. Environ. Heatth 40(2-3), 289-308 (1993)
DOI
ScienceOn
|
| 16 |
Kimura, S., Gonzalez, F.J., and Nebert, D.W., Tissue specific expression of the mouse dioxin inducible P( 1)450 and P(3)450 genes: differential transcriptional activadon and mRNA stability in liver and extrahepatic tissues. Mol. Cell. Biol. 6(5), 1471-1477 (1986)
DOI
|
| 17 |
Gonzalez, F.J. and Kimura, S., Study of P450 function using gene knockout and transgenic mice. Arch. Biochem. Biophys. 409(1), 153-158 (2003)
DOI
ScienceOn
|
| 18 |
Hammons, G.J., Yan-Sanders, Y, Jin, B., Blann, E., Kadlubar, P.R, and Lyn-Cook, B.D., Specific site methylation in the 5'-flanking region of CYP1A2 intel-individual differences in human livers. Life Sci. 69(7), 839-845 (2001)
DOI
ScienceOn
|
| 19 |
Kalow, W. and Tang, B.K., Use of caffeine metabolite rados to explore CYP1A2 and xanthine oxidase activities. Clin. Pharmacol. Ther. 50(5) Pt 1, 508-519 (1991)
DOI
ScienceOn
|
| 20 |
Kimura, S., Kawabe, M., Yu, A., and others, Carcinogenesis of the food mutagen PhIP in mice is independent of CYP1A2. Carcinogenesis 24(3), 583-587 (2003)
DOI
ScienceOn
|
| 21 |
Lamph, W.W., Wamsley, R, Sassone-Corsi, P., and Venna, I.M., Induction of proto-oncogene JUN/AP-l by semm and TPA. Nature 334(6183), 629-631 (1988)
DOI
ScienceOn
|
| 22 |
Landers, J.P. and Bunce, N.J., The Ah receptor and the mechanism of dioxin toxicity. Biohem. J. 276(Pt 2), 273-287 (1991)
|
| 23 |
Pasco, D.S., Boyum, K.W., Merchant, S.N., Chalberg, S.C., and Pagan, J.B., Transcriptional and post-transcriptional regulation of the genes encoding cytochromes P-450c and P-450d in vivo and in primary hepatocyte cultures. J. Biol. Chem. 263(18), 8671-8676 (1988)
|
| 24 |
Raha, A., Wagner, C., McDonald, R.G., and Bresnick, E., Rat liver cytosolic 4S polycylic aromatic hydrocarbon (PAH)-binding protein is glycine N-methyltransferase. J. Biol. Chem. 269, 5750-575 (1994)
|
| 25 |
Lee, W., Mitchel.l R, and Tjian, R., Purified transcnption factor AP-l interacts with TPA-inducible enhancer elements. Cell 49(6), 741-752 (1987)
DOI
ScienceOn
|
| 26 |
Relling, M.V, Lin, J.S., Ayers, G.D., and Evans, W.E., Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities. Ctin. Pharmacol. Ther. 52(6), 643-658 (1992)
DOI
ScienceOn
|
| 27 |
Burbach, K.M., Poland, A., and Bradfild, C.A., Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl. Acad. Sci. U.S.A. 89(17), 8185-8189 (1992)
DOI
ScienceOn
|
| 28 |
Mendel, D.B. and Crabtree, G.R., HNF-l, a member of a novelclass of dimerizing homeodomain proteins. J. Biol. Chem 266(2), 677-680 (1991)
|
| 29 |
Murata, M., Watanabe, M., Yamanaka, M., Kubota, Y, Ito, H.,Nagao, M., Katoh, T., Kamataki, T, Kawamura, J., Yatani, R.,and Shiraishi, T., Genetic polymorphisms in cytochrome P450(CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase(GST) Ml and GSTTl and susceptibility to prostate cancer inthe Japanese population. Cancer Letters 165(2), 171-177(2001)
DOI
ScienceOn
|
| 30 |
Nemoto, N. and Sakurai, J., Activation of Cyplal and Cyp1a2 genes in adult mouse hepatocytes in primary culture. Jpn. J. Cancer. Res. 84(3), 272-278 (1993)
DOI
|
| 31 |
Horbach, G.J., Van Asten, J.G., and Van Bezooijen, C.R, The influence of age on the inducibility of rat liver cytochrome P450IA1 (CYPIAl) and P450IA2 (CYPIA2) mRNAs. Mutat. Res. 237(3-4), 117-121 (1990)
DOI
ScienceOn
|
| 32 |
Chung, I. and Bresnick, E., 3-Methylcholanthrene-mediated induction of cytochrome P4501A2 in human hepatoma HepG2 cells as quantified by the reverse transcnption-polymerase chain reaction. Arch. Biochem. Biophys. 314(1), 75-81 (1994)
DOI
ScienceOn
|
| 33 |
Nelson, D.R., Zeldin, D.C., Hoffman, S.M., Maltais, L.J., Wain, H.M., and Nebert, D.W., Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, Pseudogenes and alternative-splice variants. Pharmacogenetics 14(1), 1-18 (2004)
DOI
ScienceOn
|
| 34 |
Raval, R, Iversen, P.L., and Bresnick, E., Induction of cytochromes P450IA1 and P450IA2 as determined by solution hybhdization. Biochem. Pharmacol, 41(11), 1719-1723 (1991)
DOI
ScienceOn
|
| 35 |
Thomas, P.E., Reik, L.M., Ryan, D.E., and Levin, W., Induction of two immunochemically related rat liver cytochrome P-450 isozymes, cytochromes P-450c and P-450d, by structurally diverse xenobiotics. J. Biol. Chem. 258(7), 4590-4598 (1983)
|
| 36 |
Butler, M.A., Iwasaki, M., Guengerich, F.P, and Kadlubar, F.R, Human cytochrome P-450PA (P-450IA2), the phenacetin 0 deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. U.S.A. 86(20), 7696-7700 (1989)
DOI
PUBMED
ScienceOn
|
| 37 |
Nakajima, M., Yokoi, T., Mizutani, M., Kinoshita, M., Funayama, M., and Kamataki, T., Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans. J. Biochem. (Tokyo) 125(4), 803-808 (1999)
DOI
|
| 38 |
Silver, G. and Krauter, K.S., Expression of cytochromes P-450c and P-450d mRNAs in cultured rat hepatocytes. 3-Me thylcholanthrene induction is regulated primarily at the post-transcriptional level. J. Biol. Chem. 263(24), 11802-11807(1988)
|
| 39 |
noassay detects cytochrome P-450 in human placenta and lymphocytes. Science 228(4698), 490-492 (1985)
DOI
PUBMED
|
| 40 |
Gillner, M., Brittebo, E.B., Brandt, I., Soderkvist, R, Appelgren, L.E., and Gustafsson, J.A., Uptake and specific binding of 2,3,7,8-tetrach1orodibenzo-p-dioxin in the olfactory mucosa of mice and rats. Cancer Res. 47(15), 4150-4159 (1987)
|
| 41 |
Lin, L., Yang, R, Ye, Z., Xu, E., Yang, C., Zhang, C., Wu, D., and Nebert, D.W., Case-control study of cigarette smoking and primary hepatoma in an aflatoxin-endemic region of China: a protective effect. Pharmacogenetics 1(2), 79-85 (1991)
DOI
ScienceOn
|
| 42 |
Chung, I., Human CYP1A2 promoter fused-luciferase gene constructs hardly respond to polycyclic hydrocarbons in tansient transfection study in HepG2 cells. Journal. of Toxi cology and Public Health 16(2), 95-100 (2000)
|
| 43 |
Pasco, D.S., Boyum, K.W., Elbi, C., Siu, C.S., and Fagan, J.B., Inducer-dependent transcriptional activation of the P4501A2 gene in vivo and in isolated hepatocytes. J. Biol. Chem. 268(2), 1053-7 (1993)
|
| 44 |
Tronche, F. and Yaniv, M., HNFl, a homeoprotein member of the hepatic transcription regulatory network. Bioessays 14(9), 579-587 (1992)
DOI
PUBMED
|
| 45 |
Imbra, R.J. and Kahn, M., Metallothionem gene expression is regulated by serum factors and activators of protein kinase C. Mol. Cell. Biol. 7(4), 1358-1363 (1987)
DOI
|
| 46 |
Koser, P.L., Faletto, M.B., Maccubbin, A.E., and Gurtoo, H.L., The genetics of aflatoxin Bl metabolism. Association of the induction of aflatoxin Bl-4-hydroxylase with the tran-sc riptional activation of cytochrome P3-450 gene. J. Biol. Chem. 263(25), 12584-12595 (1988)
|
| 47 |
Postlind, H., Vu, T.R, Tukey, R.H., and Quattrochi, L.C., Response of human CYPl-luciferase plasmids to 2,3,7,8-tetrach1orodibenzo-p-dioxin and polycyclic aromatic hydrocarbons. Toxicol. Appl. Phannacol. 118, 255-262 (1993)
DOI
ScienceOn
|
| 48 |
Quattrochi, L.C., Shih, H., and Pickwell, G.V., Induction of the human CYP1A2 enhancer by phorbol ester. Arch. Biochem. Biophys. 350(1), 41-48 (1998)
DOI
ScienceOn
|
| 49 |
Sesardic, D., Boobis, A.R., Edwards, R.J., and Davies, D.S., A form of cytochrome P450 in man, orthologous to form d in the rat, catalyses the O-deethylation of phenacetin and is inducible by cigarette smoking. Br. J. Clin. Pharmacol. 26(4), 363-372(1988)
DOI
ScienceOn
|
| 50 |
Wrighton, S.A., Campanile, C., Thomas, P.E., Maines, S.L., Watldns, P.B., Parker, G., Mendez-Rcon, G., Haniu, M., Shively, J.E., Levin, W., and Guzelian, P.S., Identification of a human liver cytochrome P-450 homologous to the major isosafole-inducible cytochrome P-450 in the rat. Mol. Pharmacol. 29(4), 405U10 (1986)
|
| 51 |
Hakkola, J., Raunio, H., Purkunen, R., Pelkonen, O., Saahkoski, S., Cresteil, T, and Pasanen, M., Detection of cytochrome P450 gene expression in human placenta in first trimester of pregnancy. Biochem. Pharmacol. 52(2), 379-383 (1996)
DOI
ScienceOn
|
| 52 |
Raha, A., Joyce, T, Gusky, S., and Bresnick, E., Glycine N-methyltransferase is a mediator of cytochrome P4501A1 gene expression. Arch. Biochem. Biophys. 322, 395-404 (1995)
DOI
ScienceOn
|
| 53 |
Sterling, K., Raha, A., and Bresnick, E., Induction of CYP1A1 gene expression in mouse hepatoma cells by benzo[e]Pyrene, a ligand of the 4S polycyclic hydrocarbon-binding protein.Toxicol. Appl. Pharmacol. 128(1), 18-24 (1994)
DOI
ScienceOn
|
| 54 |
Ding, X.X., Koop, D.R., Cmmp, B.L., and Coon, M.J., Immunochemical identification of cytochrome P-450 isozyme 3a (P-450ALC) in rabbit nasal and kidney microsomes andevidence for differential induction by alcohol. Mol. Pharmacol.30(4), 370-378 (1986)
|
| 55 |
Chung, I. and Bresnick, E., Identification of positive and negative regulatory elements of the human cytochrome P4501A2 (CYP1A2) gene. Arch. Biochem. Biophys. 338(2), 220-226 (1997)
DOI
ScienceOn
|
| 56 |
Cheung, C., Akiyama, T.E., Kudo, G., and Gonzalez, F.J., Hepaticexpression of cytochrome P450s in hepatocyte nuclear factor l-alpha (HNFlalpha)-deficient mice. Biochem. Pharmacol. 66(10), 2011-2020 (2003)
DOI
PUBMED
ScienceOn
|
| 57 |
Nebert, D.W. and Jones, J.E., Regulation of the mammalian cytochrome P1-450 (CYP1A1) gene. Int. J. Biochem. 21(3), 243-52 (1989)
DOI
ScienceOn
|
| 58 |
Quattrochi, L.Q, Vu, T., and Tukey, R.H., The human CYP1A2 gene and induction by 3-methylcholanthrene. J. Biol. Chem. 269, 6949-6954 (1994)
|
| 59 |
Wei, C., Caccavale, R.J., Kehoe, J.J., Thomas, P.E., and Iba, M.M., CYP1A2 is expressed along with CYP1A1 in the human lung. Cancer Lett. 171(1), 113-120 (2001)
DOI
ScienceOn
|
| 60 |
Pasanen, M., Haaparanta, T, Sundin, M., Sivonen, R, Vakakangas, K., Raunio, H., Hines, R., Gustafsson, J.A., and Pelkonen, O., Immunochemical and molecular biological studies on human placental cigarette smoke-inducible cytochrome P-450-dependent monooxygenase activities. Toxicotogy 62(2), 175-187 (1990)
|
| 61 |
Ding., X.X. and Coon, M.J., Immunochemical characterization of multiple forms of cytochrome P-450 in rabbit nasal microsomes and evidence for tissue-specific expression of P-450s NMa and NMb. Mol. Pharmacol. 37(4), 489-496 (1990)
|
| 62 |
Massari, M.E. and Murre, C., Helix-loop-helix proteins: re gulators of transcription in eucaryotic organisms. Mol. Cell Biol. 20(2), 429-440 (2000)
DOI
ScienceOn
|
| 63 |
Ratanasavanh, D., Beaune, R, Morel, R, Flinois, J.R, Guengerich, F.R, and Guillouzo, A,, Intralobular distribution and quantitation of cytochrome P-450 enzymes in human liver as a function of age. Hepatotogy 13(6), 1142-1151 (1991)
|
| 64 |
Suzuki, T., Okuno, H., Yoshida, T., Endo, T., Nishina, H., and Iba, H., Difference in transcriptional regulatory function between c-Fos and Fra-2. Nucleic Acids Res. 19(20), 5537-5542 (1991)
DOI
ScienceOn
|
| 65 |
Aoyama, T., Gonzalez, F.J. and Gelboin, H.V., Human cDNA-expressed cytochrome P450IA2: mutagen activation and substrate specificity. Mol. Carcinog. 2(4), 192-198 (1989)
DOI
ScienceOn
|
| 66 |
Nakajima, M., Iwanari, M., and Yokoi, T., Effects of histone deacetylation and DNA methylation on the constitutive and TCDD-inducible expressions of the human CYPl family in MCF-7 and HeLa cells. Toxicol. Lett. 144(2), 247-256 (2003)
DOI
ScienceOn
|
| 67 |
Sherson, D., Sigsgaard, T., Overgaard, E., Loft, S., Poulsen, H.E., and Jongeneelen, F.J., Interaction of smoking, uptake of polycyclic aromatic hydrocarbons, and cytochrome P450IA2 activity among foundry workers. Br. J. Ind. Med. 49(3), 197-202 (1992)
|
| 68 |
Pineau, T., Daujat, M., Pichard, L., Girard, F, Angevain, J., Bonfils, C., and Maurel, P., Developmental expression of rabbit cytochrome P450 CYP1A1, CYP1A2 and CYP3A6 genes. Effect of weaning and nfampicin. Eur. J. Biochem. 197(1), 145-153 (1991)
DOI
ScienceOn
|
| 69 |
Hoffman, E.C., Reyes, H., Chu, F.R, Sander, R, Conley, L.H., Brooks, B.A., and Hankinson, O., Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252(5008), 954-958 (1991)
DOI
PUBMED
|
| 70 |
Schweikl, H., Taylor, J.A., Kitareewan, S., Linko, R, Nagomey, D., and Goldstein, J.A., Expression of CYP1A1 and CYP1A2 genes in human liver. Pharmacogenetics 3(5), 239-249 (1993)
DOI
ScienceOn
|
| 71 |
Ilett, K.R, Casdeden, W.M., Vandongen, Y.K., Stacey, M.C., Butler, M.A., and Kadlubar, F.F., Acetylation phenotype and cytochrome P450IA2 phenotype are unlikely to be associated with peripheral arterial disease. Clin. Pharmacol. Ther. 54(3), 317-322 (1993)
DOI
ScienceOn
|
| 72 |
Gonzalez, F.J., Tukey, R.H. and Nebert, D.W., Stmctural gene products of the Ah locus. Transcriptional regulation of cytochrome P1-450 and P3-450 mRNA levels by 3-methylcholanthrene. Mol. Pharmacol. 26(1), 117-121 (1984)
|
| 73 |
Kokwaro, G.O., Glazier, A.R, Ward, S.A., Breckenridge, A.M., and Edwards, G., Effect of malaria infection and endotoxin-induced fever on phenacetin O-deethylation by rat liver microsomes. Biochem. Pharmacol. 45(6), 1235-1241 (1993)
|
| 74 |
Morville, A.L., Thomas, R, Levin, W., Reik, L., Ryan, D.E., Raphael, C., and Adesnik, M., The accumulation of distinct mRNAs for the immunochemically related cytochromes P-450c and P-450d in rat liver following 3-methylcholanthrene treatment. J. Biol. Chem. 258(6), 3901-3906 (1983)
|
| 75 |
Pickwell, G.V., Shih, H., and Quattrochi, L.C., Interaction of upstream stimulatory factor proteins with an E-box located within the human CYP1A2 S'-tlanking gene contributes tobasal transcriptional gene activation. Biochem. Pharmacol. 65(7), 1087-1096 (2003)
DOI
ScienceOn
|
| 76 |
Diaz, D., Fabre, I., Daujat, M., Saint Aubert, B., Bories, R., Michel, H., and Maurel, R, Omeprazole is an aryl hy drocarbon-like inducer of human hepatic cytochrome P450. Gastroenterology 99(3), 737-747 (1990)
DOI
|
| 77 |
Imaoka, S., Terano, Y., and Funae, Y, Changes in the amount of cytochrome P450s in rat hepatic microsomes with starvation. Arch. Biochem. Biophys. 278(1), 168-177 (1990)
DOI
ScienceOn
|
| 78 |
McKinnon, R.A., Hall, P.D., Quattrochi, L.C., Tukey, R.H., and McManus, M.E., Localization of CYP1A1 and CYP1A2 messenger RNA in normat human liver and in hepatocellular carcinoma by in situ hybridization. Hepatotogy 14(5), 848-856 (1991)
|
| 79 |
Padgham, C.R., Paine, A.J., Phillips, I.R., and Shephard, E.A., Maintenance of total cytochrome P-450 content in rat hepatocyte culture and the abundance of CYP1A2 and CYP2B1/2 mRNAs. Biochem. J. 285(Pt3), 929-932 (1992)
DOI
|
| 80 |
Chung, I. and Bresnick, E., Regulation of the constitutive expression of human CYP1A2 gene: cis elements and their interactions with proteins. Mol. Pharmacol. 47, 677-685 (1995)
|
| 81 |
Sesardic, D., Pasanen, M., Pelkonen, O., and Boobis, A.R., Differential expression and regulation of members of the cy tochrome P450IA gene subfamily in human tissues. Ca rcinogenesis 11(7), 1183-1188 (1990)
|
| 82 |
Okino, S.T., Pendurthi, U.R., and Tukey, R.H., Phorbol esters inhibit the dioxin receptor-mediated transcriptional activation of the mouse Cypla-l and Cyp1a-2 genes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Biol. Chem. 267(10), 6991-6998 (1992)
|
| 83 |
Sachse, C., Brockmoller, J., Bauer, S., and Roots, I., Functional signiScance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br. J. Ctin. Pharmacol. 47(4), 445-449 (1999)
DOI
ScienceOn
|
| 84 |
Gonzalez, FJ. and Nebert, D.W,, Evoludon of the P450 gene superfamily: animal-plant 'warfare', molecular drive and human genetic differences in drug oxidation. Trends Genet. 6(6), 182-186(1990)
DOI
|
| 85 |
Fisher, J.M., Wu, L., Denison, M.S., and Whitlock, Jr. J.R., Organization and function of a dioxin-responsive enhancer. J. Bio. Chem. 265, 9676-9681 (1990)
|
| 86 |
Murata, M., Watanabe, M., Yamanaka, M., Kubota,Y, Ito, H.,Nagao, M., Katoh, T., Kamataki, T, Kawamura, J., Yatani, R.,and Shiraishi, T, Genetic polymorphisms in cytochrome P450(CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST)Ml and GSTTl and susceptibility to prostate cancer in theJapanese population. Cancer Letters 165(2), 171-177 (2001)
DOI
ScienceOn
|
webmaster
